Both in Pharmaceuticals
uniQure vs Nuvation Bio
Over the past year QURE returned −33.1% and NUVB returned −9.8%; their daily moves had a correlation of 0.13.
QURE −33.1% NUVB −9.8%Growth of $1, one year, split-adjusted
| Metric | QURE | NUVB |
|---|---|---|
| Price | $22.93 | $4.67 |
| Market cap | $1.59B | $1.64B |
| Today | −3.94% | −0.53% |
| 1 month | −0.6% | −4.4% |
| 6 months | +0.5% | −7.4% |
| Year to date | −4.2% | −47.9% |
| 1 year | −33.1% | −9.8% |
| Revenue growth (YoY) | +11.0% | +555.6% |
| Gross margin | 94.0% | 73.0% |
| Net margin | −1387.8% | −198.3% |
| P/E (TTM) | — | — |
| Price / sales | 85.2× | 9.6× |
| Net cash | $760.2M | $399.4M |
| Dividend yield | — | — |
| Volatility (60d) | 109.2% | 50.7% |
| Short % of float | 13.2% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).